REFERENCES
1. Clinical guidelines «Unsuccessful attempt to stimulate labor (preparation of the cervix for childbirth and labor induction)». Moscow, 2021. (in Russian)
2. Timmons B., Akins M., Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab. 2010; 21 (6): 353–61.
3. Nakano T., et al. Factors associated with emergency cesarian delivery during induction of labor in nulliparous women aged 35 years or older at term. J Obstet Gynaecol Res. 2018; 44 (9): 1747–51.
4. Bergholt T., et al. Maternal age risk of cesarean section in women with induced labor at term – a Nordic register-based study. Acta Obstet Gynecol Scand. 2020; 99 (2): 283–9.
5. Maged A.M., et al. Effect of maternal obesity on labor induction in postdate pregnancy. Arch Gynecol Obstet. 2018; 298 (1): 45–50.
6. Pevzner L., Rayburn W.F., Rumney P., Wing D.A. Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol. 2009; 114 [2 (1)]: 261–7.
7. Carlson N.S., Hernandez T.L., Hurt K.J. Parturition dysfunction in obesity: time to target the pathobiology. Reprod Biol Endocrinol. 2015; 13 (1): 1–14.
8. Garabedian M.J., et al. Extrime morbid obesity and labor outcome in nulliparous women at term. Am J Perinatol. 2011; 28 (9): 729–34.
9. Gibbs Pickens C.V., et al. Term Elective induction of labor and pregnancy outcomes among obese women and their offspring. Obstet Gynecol. 2018; 131 (1): 12–22.
10. Kawalita T., et al. 53: prediction vaginal delivery in nulliparous women undergoing induction of labor. Am J Obstet Gynecol. 2017; 216 (1): S38–9.
11. Hermann M., et al. The risk of prelabor and intrapartum cesarean delivery among overweight and obese women: possible preventive actions. Am J Obstet Gynecol. 2015; 212 (2): 241.е1–9.
12. Melamed N., et al. Induction of labor before 40 weeks is associated with lower rate of caesarean delivery in women with gestational diabetes mellitus. Presented at the 36th Annual Meeting of the Society for Maternal-Fetal Medicine, Atlanta, GA, February 1–6, 2016. Am J Obstet Gynecol. 2016; 214 (3): 364.e1–8.
13. Souter V., et al. Maternal and newborn outcomes with elective induction of labor at term. Am J Obstet Gynecol. 2019; 220 (3): e1–11.
14. Chodankar R., Sood A., Gupta J. An overview of the past, current and future trends for cervical ripening in induction of labour. Obstet Gynecol. 2017; 19 (3): 219–26.
15. Gupta J., et al. Synthetic osmotic dilators in the induction of labor – an international multicentre observational study. Eur J Obstet Gynecol Reprod Biol. 2018; 229: 70–5.
16. Marconi A. Recent advances in the induction of labor [version 1; peer review: 2 approved]. F1000Research. 2019; 8 (4): 567–82.
17. Penfield C.A., Wing D.A. Labor induction techniques: which is the best? Obstet Gynecol Clin North Am. 2017; 44 (4): 567–82.
18. Predictive obstetrics. In: V.E. Radzinsky, S.A. Knyazev, I.N. Kostin, et al.; V.E. Radzinsky, S.A. Knyazev, I.N. Kostin (eds). Moscow: Redaktsiya zhurnala StatusPraesens, 2021: 520 p. (in Russian)
19. Arulkumaran S., Gibb D.M., Tamby Raja R.L., Heng S.H., Ratnam S.S. Failed induction of labour. Aust N Z J Obstet Gynaecol. 1985; 25 (3): 190–3.
20. Xenakis E.M., Piper J.M., Conway D.L., Langer O. Induction of labor in the nineties: conquering the unfavorable cervix. Obstet Gynecol. 1997; 90 (2): 235–9.
21. Grobman W.A., et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018; 379 (6): 513–23.
22. Alfirevic Z., Keeney E., Dowswell T., et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ. 2015; 350: h217.
23. Vannuccini S., Bocchi C., Severi F.M. et al. Endocrinology of human parturition. Ann Endocrinol. 2016; 77 (2): 105–13.
24. Levine L.D., Downes K.L., Elovitz M.A., et al. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol. 2016; 128: 1357–64.
25. Eser A., Ozkaya E., Abide C.Y., et al. Transcervical Foley balloon catheter and vaginal prostaglandin E2 insert combination vs. vaginal prostaglandin E2 insert only for induction of labor at term: a randomized clinical trial. Arch Gynecol Obstet. 2019; 299: 451–7.
26. Konopka C.K., Glanzner W.G., Rigo M.L., et al. Responsivity to PGE2 labor induction involves concomitant differential prostaglandin E receptor gene expression in cervix and myometrium. Genet Mol Res. 2015; 14 (3): 10 877–87.
27. Witter F.R., Mercer B.M. Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. J Matern Fetal Med. 1996; 5: 64–9. URL: https://doi.org/10.1002/(SICI)1520-6661(199603/04)5:2<64::AID-MF M3>3.0.CO;2-O
28. Wing D.A. et al. Misoprostol Vaginal Insert and Time to Vaginal Delivery. Obstet Gynecol. 2013; 122: 201–9. DOI: https://doi.org/10.1097/AOG.0b013e3182 9a2dd6
29. Facchinetti F., et al. Elective cervical ripening in women beyond the 290th day of pregnancy: a randomized trial comparing 2 dinoprostone preparations. J Reprod Med. 2007; 52: 945–9.
30. Bierut A., et al. Misoprostol vaginal insert in labor induction: a cost-consequences model for 5 European countries-an economic evaluation supported with literature review and retrospective data collection. Adv Ther. 2016; 33 (10): 1755–70. DOI: https://doi.org/10.1007/s12325-016-0397-3
31. Triglia M.T. A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score ≤ 4. Acta Obstet Gynecol Scand. 2010; 89 (5): 651–7. DOI: https://doi.org/10.3109/00016340903575998
32. Hill L.M., Breckle R.J., Wolfgram K.R., O’Brien P.C. Oligohydramnios: ultrasonically detected incidence and subsequent fetal outcome. Am J Obstet Gynecol. 1983; 147: 407–10.
33. McCurdy C.M. Jr, Seeds J.W. Oligohydramnios: problems and treatment. Semin Perinatol. 1993; 17: 183–96.
34. Morris R.K., Meller C.H., Tamblyn J., Malin G.M., Riley R.D., Kilby M.D., et al. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG. 2014; 121: 686–99.
35. Kansu-Celik H., et al. Prostaglandin E2 induction of labor and cervical ripening for term isolated oligohydramnios in pregnant women with Bishop score ≤5. J Chin Med Assoc. 2017; 80: 169–17. DOI: https://doi.org/10.1016/j.jcma.2016.07.004
36. Tenore J.L. Methods for cervical ripening and induction of labor. Am Fam Physician. 2003; 67: 2123–8.
37. Hamilton B.E., Martin J.A., Osterman M.J., et al. Births: final data for 2014. Natl Vital Stat Rep. 2015; 64 (12): 1–64.
38. Levine L.D., Downes K.L., Elovitz M.A., et al. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol. 2016; 128: 1357–64.
39. Coste Mazeau P., Hessas M., Martin R., et al. Is there an interest in repeating the vaginal administration of dinoprostone (Propess®), to promote induction of labor of pregnant women at term? (RE-DINO): study protocol for a randomized controlled trial. Trials. 2020; 21: 51. DOI: https://doi.org/10.1186/s13063-019- 3985-0
40. Chiossi G., D’Amico R., Tramontano A.L., Sampogna V., Laghi V., Facchinetti F. Prevalence of uterine rupture among women with one prior low transverse cesarean and women with unscarred uterus undergoing labor induction with PGE2: A systematic review and meta-analysis. PLoS One. 2021; 16 (7): e0253957. DOI: https://doi.org/10.1371/journal.pone.0253957